Scientific Review Branch (SRB)
- Quentin Li, M.D., Ph.D.
Scientific Review Officer
- Tel 240-858-3914
- P.O. Box 12233Mail Drop K3-05Durham, N.C. 27709
Quentin Li is an M.D. by training and has worked as a physician in the First Hospital of Sun Yat-sen University in southern China. He came to the U.S. to pursue an M.S. degree in microbiology and immunology and a Ph.D. in pharmacology and therapeutics at the University of Maryland School of Medicine, where he studied the roles of macrophage lysosomal proteinases and glial chemokines in the pathogenesis of multiple sclerosis. Quentin Li completed his postdoctoral training in oncology and cancer biology in the Medical Oncology Branch at the National Cancer Institute (NCI) before joining the West Virginia University School of Medicine as a faculty member in the Department of Microbiology, Immunology and Cell Biology and the Mary Babb Randolph Cancer Center. There, he led a research team studying DNA damage repair and molecular mechanism of cisplatin drug resistance in ovarian cancer and other tumors. His work was funded by the National Institutes of Health (NIH) and private foundations.
In 2006, Quentin Li returned to the NIH, first at the National Institute of Allergy and Infectious Diseases (NIAID), studying azole drug resistance in fungal infections using molecular genetics and genomics approaches, and then again at the NCI investigating the mechanism of histone methylation in the epigenetic regulation of immediate early gene expression in T cells and leukemia cells. In recent years at the Urologic Oncology Branch, he conducted translational and preclinical studies in bladder cancer using epigenetic and proteomic approaches. Most recently, Quentin Li transitioned to an SRO detail at the Center for Scientific Review (CSR) prior to joining as a Scientific Review Officer (SRO) in the Division of Extramural Research and Training at the National Institute of Environmental Health Sciences (NIEHS).
Collectively, Quentin Li has amassed nearly 30 years of basic, translational, preclinical, and clinical research expertise in multiple disciplines and fields of biomedical sciences. He serves as a reviewer for two U.S. research and development foundations and for numerous scientific journals. During his time, he has authored over 110 peer-reviewed research articles and reviews and presented more than 70 papers at national and international conferences and scientific meetings.